Solventum, formerly 3M Health Care, announced today the launch of the 3Mâ„¢ Harvest RC Centrate Chromatographic Clarifier, a ...
With fresh, positive data in hand, Biohaven now believes its medicine could be the first to receive FDA approval for spinocerebellar ataxia.
The companies now plan on starting this year another large study of their drug, dapirolizumab pegol, in the hopes that they can confirm its safety and effectiveness to drug regulators.